Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1Expanded_access 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Glioma 11Glioblastoma 6Brain Neoplasms 4Neuroendocrine Tumors 3Hypoglycemia 3Congenital Hyperinsulinism 3Recurrence 2Parkinson Disease 2Oligodendroglioma 2Neuroblastoma 2Insulinoma 2Hyperinsulinism 2Gliosarcoma 2Ependymoma 2Astrocytoma 2Pheochromocytoma 1Parkinsonian Disorders 1Parathyroid Neoplasms 1Optic Nerve Glioma 1Neoplasms, Neuroepithelial 1Neoplasms 1Multiple Endocrine Neoplasia 1Lewy Body Disease 1Infant, Newborn, Diseases 1Hyperparathyroidism 1Hypercalcemia 1Glucose Metabolism Disorders 1Glioma, Subependymal 1Endocrine System Diseases 1Carcinoma, Medullary 1

Interventions

3-Iodobenzylguanidine 8Temozolomide 6lutetium Lu 177 dotatate 5gallium Ga 68 dotatate 4anlotinib 4Specimen Handling 4Everolimus 4Radiotherapy 3Phenoxybenzamine 3Magnetic Resonance Spectroscopy 3Doxorubicin 36-fluorodopamine 3olaparib 2cabozantinib 2belzutifan 2Nivolumab 2Ifosfamide 2Fluorodeoxyglucose F18 2Filgrastim 2Doxazosin 2Dexmedetomidine 2Capecitabine 2Biopsy 2Axitinib 23-fluorobenzylguanidine 2177Lu-octreotide, DOTA(0)-Tyr(3)- 2veliparib 1vatalanib 1vandetanib 1tipifarnib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Pheochromocytoma × fluorodopa F 18 × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡